SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-025203
Filing Date
2023-09-05
Accepted
2023-09-05 16:15:57
Documents
15
Period of Report
2023-09-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dmtp20230903_8k.htm   iXBRL 8-K 37237
2 EXHIBIT 10.1 ex_566855.htm EX-10.1 49410
3 EXHIBIT 10.2 ex_566856.htm EX-10.2 78260
  Complete submission text file 0001437749-23-025203.txt   328956

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA dmac-20230903.xsd EX-101.SCH 3408
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20230903_def.xml EX-101.DEF 11791
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20230903_lab.xml EX-101.LAB 15827
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20230903_pre.xml EX-101.PRE 12006
9 EXTRACTED XBRL INSTANCE DOCUMENT dmtp20230903_8k_htm.xml XML 2646
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36291 | Film No.: 231235948
SIC: 2834 Pharmaceutical Preparations